Orchestra BioMed Holdings Income Statement (2022-2025) | OBIO

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.87M0.40M1.16M1.10M1.16M0.92M0.42M0.26M0.62M0.78M0.99M0.25M0.87M0.84M0.86M
Gross Profit 0.82M0.34M1.11M1.05M1.12M0.86M0.38M0.21M0.59M0.73M0.92M0.20M0.82M0.79M0.81M
Operating items
Depreciation & Amortization - Total 0.07M0.07M0.08M0.08M0.08M0.08M0.08M
Research & Development 3.47M5.03M5.90M7.54M8.25M8.50M8.56M8.51M9.11M11.13M11.60M10.97M13.48M13.85M14.03M
Wages, Salaries and Other 5.49M5.91M6.03M5.17M6.66M7.00M6.82M
Selling, General & Administrative 2.48M2.95M5.28M3.33M4.41M5.32M6.34M4.18M5.90M6.47M5.67M5.90M6.26M6.26M7.10M
Other Operating Expenses -0.60M-0.21M-0.21M0.08M0.60M0.91M1.21M-0.34M0.96M0.88M0.92M0.52M0.17M-0.04M-0.52M
Operating Expenses 5.99M8.04M11.23M10.93M12.71M13.87M14.94M12.74M15.04M17.64M17.33M16.93M19.79M20.16M21.17M
Operating Income -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M
EBIT -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M
Non-operating items
Non Operating Investment Income -0.22M1.73M-0.31M-0.17M-0.03M-0.06M0.29M-0.29M-0.04M-0.02M0.12M-0.18M-0.01M-0.02M0.03M
Interest & Investment Income 0.92M1.11M1.02M0.90M0.92M0.52M0.17M-0.04M-0.52M
Other Non Operating Income -0.01M
Non Operating Income -0.01M
Net income details
EBT -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Profit After Tax -5.73M-7.85M-10.28M-9.75M-10.94M-12.05M-13.32M-12.82M-13.46M-15.98M-15.43M-16.16M-18.75M-19.36M-20.83M
Income from Continuing Operations -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Consolidated Net Income -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Income towards Parent Company -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Net Income towards Common Stockholders -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Additional items
EPS (Basic) -0.62-0.77-0.51-0.44-0.40-0.35-0.38-0.37-0.38-0.45-0.41-0.43-0.49-0.50-0.40
EPS (Weighted Average and Diluted) -0.560.03-0.51-0.44-0.40-0.35-0.38-0.37-0.38-0.45-0.41-0.43-0.49-0.50-0.40
Shares Outstanding (Weighted Average) 20.45M20.45M11.21M30.63M30.63M35.76M35.74M35.74M35.78M35.79M37.82M38.01M38.31M53.96M53.96M
Shares Outstanding (Diluted Average) 9.23M18.45M20.19M14.99M27.64M34.61M35.24M33.23M35.78M35.80M37.62M36.82M38.24M38.39M52.19M
EBITDA -5.73M-7.85M-10.28M-9.76M-10.97M-12.11M-13.30M-12.75M-13.46M-15.99M-15.30M-16.20M-18.77M-19.38M-20.80M
Shares Outstanding 10.14M20.19M20.19M35.69M31.74M35.74M35.74M35.78M35.78M35.82M37.94M38.19M38.31M38.64M56.46M